A multicenter, open-label, randomized, phase III study to compare the efficacy and safety of lenvatinib in combination with pembrolizumab versus treatment of physician's choice in patients with advanced endometrial cancer
Articles > Article · 2021
Authors: Vicky Makker, Nicoletta Colombo, Antonio Casado Herráez, Alessandro Santin, Emeline Colomba, David Miller, Keiichi Fujiwara, Sandro Pignata, Sally Baron-Hay, Isabelle Ray-Coquard, Ronnie Shapira-Frommer, Kimio Ushijima, Jun Sakata, Kan Yonemori, Yong Man Kim, Eva Guerra, Ulus Ali ŞANLI, Mary McCormack, Jie Huang, Alan Smith, Stephen Keefe, Lea Dutta, Robert Orlowski, Domenica Lorusso
Gynecologic Oncology, International, WoS, 2021, vol 162, pp S4-S4